Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call

  //health-fitness.news-articles.net/content/2011/ .. r-end-financial-results-and-conference-call.html
  Published in Health and Fitness on Tuesday, December 6th 2011 at 5:40 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year... -- ALISO VIEJO, Calif., Dec. 6, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about AVNR

ALISO VIEJO, Calif., Dec. 6, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) will report financial results for the quarter and year ended September 30, 2011 after market close on Monday, December 12, 2011. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1-877-558-3407
International callers: +1-706-679-1941
Passcode: 33791527

Webcast information: Visit [ http://www.avanir.com ].

A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855 859-2056 for domestic callers, or +1-404 537-3406 for international callers, and entering reservation code 33791527.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

^©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.